NCT07219368View on ClinicalTrials.gov

A First-in-Human Single and Multiple Ascending Dose Study of MT-201

PHASE1RecruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

October 8, 2025

Primary Completion Date

November 24, 2026

Study Completion Date

December 31, 2026

Conditions
Healthy Volunteer
Interventions
DRUG

MT-201

MT-201

DRUG

Placebo

Placebo

Trial Locations (1)

92121

RECRUITING

Mirador Clinical Department, San Diego, California 92121, San Diego

Sponsors
All Listed Sponsors
lead

Mirador Therapeutics, Inc.

INDUSTRY

NCT07219368 - A First-in-Human Single and Multiple Ascending Dose Study of MT-201 | Biotech Hunter | Biotech Hunter